Stock screenerAll disclosures →
EDGAR →
RMD
Conviction 45HealthcareScan · Thu, Sep 24, 2026Resmed Inc (RMD) closed at $221.92 (-0.17%) on Sep 24, 2026. Price is above its 50-day and below its 200-day moving average. RSI(14) 46, RS Rating 35, -21.7% from its 52-week high, -9.3% year to date. Sector: Healthcare · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
RMD$221.92-0.17%
ResistanceSupportVol 14Insider sellCongress buyCongress sellVol MA14 1.36M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
WSB mentions · 24h changelatest +0.00%· 1 mentions
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price221.92
Change-0.17%
Gap+0.36%
Rel volume0.76×
Avg volume1.37M
Avg $ vol311.44M
SMA 20226.93
SMA 50220.32
SMA 200226.59
Price vs 50+0.72%
Price vs 200-2.07%
MA stackmixed
50/200 cross—
Supertrenddown · 237.28
RSI (14)46
MACD hist-1.06
MACD cross—
Stoch %K / %D33 / 32
ADX (14)13
+DI / −DI19 / 20
RSI divergence—
MACD divergence—
ATR %2.68%
ADR %2.47%
52w high283.28
52w low182.82
From 52w high-21.66%
Above 52w low+21.38%
New 52w highNo
SqueezeOff
Bollinger width11.13%
%B0.30
Donchian pos22.99%
Donchian high242.40
Donchian low215.80
AVWAP (52w high)228.40
vs AVWAP high-2.84%
AVWAP (52w low)211.39
vs AVWAP low+4.98%
OBV trendDown
Chaikin MF (20)-0.17
Today vs 20d0.76×
Avg vol (14d)1.36M
Avg vol (20d)1.37M
Avg $ vol (20d)311.44M
Market cap32.01B
RS Rating35 / 99
RS 3m (vs SPY)+7.25%
RS 6m (vs SPY)-18.76%
RS line new highNo
Trend template3/8
Technical rank47.3
1 week-2.85%
1 month-6.20%
3 months+11.74%
6 months-1.94%
1 year-19.48%
YTD-9.35%
P/E21.01
P/B4.86
P/S5.66
P/FCF19.41
EPS10.43
Div yield1.09%
ROE23.13%
ROA16.99%
Debt/Eq0.15
Current3.10
EV/EBITDA15.12
Gross margin61.06%
Net margin26.94%
Rev growth9.85%
EPS growth8.75%
Price target241.42
Target upside8.79%
Analyst ratingHold
Institutional82.36%
Ent. value31.56B
Revenue1.43B
Net income398.73M
Gross profit890.98M
Free cash flow1.65B
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNYSE
Shares out145.06M
Employees10.6K
ListedFri, Jun 2, 1995
Free float144.48M
Float %99.2%
Short interest13.07M
Days to cover8.9d
Short volume69.5%
Squeeze score63 / 100
Next earnings—
EPS forecast—
Last EPS vs est$2.95 vs $2.90
Last surprise+1.7% beat
Setup gradeC
Conviction45 / 100
Pattern quality—
Tech rank47.3 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance240.39
Support208.90
Days since event—
Candle confirm—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in RMD · 6 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Thomas H Tuberville senate · traded 2024-05-03 | Sell | $1K–$15K | 2024-05-03 | 2026-08-05 | |
 Alan Armstrong senate · R · OK · traded 2026-03-27 | Buy | $1K–$15K | 2026-03-27 | 2026-07-21 | |
 Kelly Louise Morrison house · D · MN · traded 2025-06-04 | Sell | $1K–$15K | 2025-06-04 | 2025-06-18 | |
Kelly Louise Morrison house · D · MN · traded 2025-04-28 | Sell | $1K–$15K | 2025-04-28 | 2025-05-13 | |
 Rob Bresnahan house · PA · traded 2025-01-13 | Sell | $1K–$15K | 2025-01-13 | 2025-02-13 | |
Thomas H Tuberville senate · traded 2024-05-03 | Sell | $1K–$15K | 2024-05-03 | 2024-06-14 |
Insider activity
SEC Form 4 transactions in RMD · open-market 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Farrell Michael J. Chairman and CEO · ResMed Common Stock · 2026-08-07 | Exercise | 4.99K | $730K | 2026-08-07 | 2026-08-11 |
Farrell Michael J. Chairman and CEO · ResMed Common Stock · 2026-08-07 | Sell | 4.99K | $1.0M | 2026-08-07 | 2026-08-11 |
Farrell Michael J. Chairman and CEO · ResMed Common Stock Options · 2026-08-07 | Exercise | 4.99K | — | 2026-08-07 | 2026-08-11 |
Farrell Michael J. Chairman and CEO · ResMed Common Stock · 2026-07-07 | Exercise | 4.99K | $730K | 2026-07-07 | 2026-07-09 |
Farrell Michael J. Chairman and CEO · ResMed Common Stock · 2026-07-07 | Sell | 4.99K | $1.1M | 2026-07-07 | 2026-07-09 |
Farrell Michael J. Chairman and CEO · ResMed Common Stock Options · 2026-07-07 | Exercise | 4.99K | — | 2026-07-07 | 2026-07-09 |
Farrell Michael J. Chairman and CEO · ResMed Common Stock · 2026-06-08 | Exercise | 4.99K | $730K | 2026-06-08 | 2026-06-09 |
Farrell Michael J. Chairman and CEO · ResMed Common Stock · 2026-06-08 | Sell | 4.99K | $968K | 2026-06-08 | 2026-06-09 |
Farrell Michael J. Chairman and CEO · ResMed Common Stock Options · 2026-06-08 | Exercise | 4.99K | $0 | 2026-06-08 | 2026-06-09 |
Farrell Michael J. Chairman and CEO · ResMed Common Stock · 2026-06-08 | Other | — | — | 2026-06-08 | 2026-06-09 |
SEC filings
EDGAR filings in RMD · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.